Oddo BHF - CTP NV (CTPNV) CTP NV : Q3 2024 results: EPS outlook confirmed, albeit with lower 2024 deliveries

Report

Oddo BHF

Roy Külter ...

Steven Boumans

CTP NV : Q3 2024 results: EPS outlook confirmed, albeit with lower 2024 deliveries

>Outlook confirmed; strong Q3 deliveries; FY2024 deliveries lower - CTP confirms its €0.80 - €0.82 guidance for FY2024. The FY2024 delivery target is 1.2-1.3m sqm versus previous communicated at the high-end of the 1.0-1.5m official target. Planned 2024 deliveries are 64% pre-let (H1: 51%, Q3 2023 77% and 80%-90% target at delivery). CTP completed 545,000sqm GLA (9M 2024) at a yield on cost of 10.1% in 9M 2024 and 95% let (H1: 328,000, 92% let). Like for lik...

06/11/2024 1 EN

Underlying

CTP NV

See profile

NL00150006R6 Euronext Amsterdam Netherlands

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Roy Külter

Steven Boumans

Other Reports on these Companies

ING Financial Markets

Benelux Morning Notes

Ahold Delhaize: A strong 3Q24, driven by Europe. CFE: 3Q24 preview - able to keep net profit outlook? CTP: Good results, guidance reiterated. DEME Group: 3Q24 preview - keeping the FY outlook. Exor: Ferrari hitting Chinese wall. IBA: Contract win for E-beam sterilisation solution in the Dominican Republic. Kendrion: 3Q24 preview - harsh end markets but easy comps. Proximus: 2025 price increases on the high side, more asset sales in the pipeline. Solvay: 3Q24 results beat by 4% but on unfavourable mix, minor upside to consensus. TKH Group: 3Q24 preview - not easy out there. ...

2h 2h 1 EN

KBC Securities

Morning Notes : ABI BB, AD NA, ATEB BB, FUR NA, IBAB BB, JEN BB, SOLB BB, AZE BB, MAAT FP, CTPNV NA, DEME BB

: ABI BB, AD NA, ATEB BB, FUR NA, IBAB BB, JEN BB, SOLB BB, AZE BB, MAAT FP, CTPNV NA, DEME BB

2h / 20m 2h / 20m 1 EN

Puma : Q3 EBIT a notch above, FY 2024 outlook confirmed

>Some 5% growth but a flat operating margin - Q3 & outlook: in Q3, sales increased 5% excluding FX to € 2,308m (consensus: € 2,346m, ODDO BHFe: € 2,334m) which is 2% below the consensus in reported terms but in line with regards to currency neutral growth. Regions: EMEA did OK with +1%, Americas with +11% supported by LatAm and the US and Asia grew +3% despite a softer Chinese market. Channels: DTC+17% and Wholesale +2%. Products: Footwear +9% and Apparel -1%. EBIT ca...

1h / 39m 1h / 39m 1 EN

Oliver Metzger

Oliver Metzger

Fresenius SE & CO KGaA : Q3 review –Beat driven by Helios Germany, slight guidance increase

>Q3 review – Beat on top and bottom line - Q3 revenues of € 5,303m (-3.9% y-o-y, 2%/2% vs ODDO BHF/consensus) were driven solely by 9% organic growth. Group EBIT before special items reached € 552m (-1.3% y-o-y, margin 10.4%), 6%/3% ahead of expectations. Adjusted EPS of € 0.69 compared to our € 0.66 and the consensus’ € 0.65.Kabi -Strong growth of Biopharma, IV business with slow growth - Kabi's Q3 revenues of € 2,114m (+4.6% y-o-y) were 2%/0% vs exp...

1h / 42m 1h / 42m 1 EN

Michael B. Schäfer

Michael B. Schäfer

Evonik Industries AG : Q3 EBITDA in line, guidance confirmed; strong OpFCF of € 701m in 9M 24 points to upper end of € 760-880m implied FY range (css € 841m)

>Q3 EBITDA 1% ahead of consensus at € 577m, up 19% y/y - The group’s expected solid Q3 results came out today, with € 577m of adj. EBITDA, 1% ahead of the css, gaining 19% y-o-y (cons/ODDO € 573m/€ 564m), flat q-o-q compared to strong Q2 24 results of € 578m and in line with 'largely flat q-o-q' company guidance.Spec. additives and smart materials remain firm, maintained solid methionine prices vs. q-o-q volume recovery - net positive - Summer lull se...

1h / 46m 1h / 46m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

CTP NV : Q3 2024 results: EPS outlook confirmed, albeit with lower 2024 deliveries

Benelux Morning Notes

Morning Notes : ABI BB, AD NA, ATEB BB, FUR NA, IBAB BB, JEN BB, SOLB BB, AZE BB, MAAT FP, CTPNV NA, DEME BB

Puma : Q3 EBIT a notch above, FY 2024 outlook confirmed

Fresenius SE & CO KGaA : Q3 review –Beat driven by Helios Germany, slight guidance increase

Evonik Industries AG : Q3 EBITDA in line, guidance confirmed; strong OpFCF of € 701m in 9M 24 points to upper end of € 760-880m implied FY range (css € 841m)

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe